Simplify Logo

Full-Time

Scientist I/II

Analytical Development, LC-MS

Updated on 7/25/2024

Tessera Therapeutics

Tessera Therapeutics

201-500 employees

Develops gene writing genome engineering technology

Data & Analytics
Hardware
Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • BS in analytical chemistry, biochemistry, or relevant discipline with 8+ years of relevant experience, or M.S. with 6+ years relevant industry experience, or PhD with 1+ years industry experience
  • Strong background in LCMS (required) and HPLC
  • Experience with RNA or Oligonucleotide analytical chemistry and biophysical techniques
  • Analyzing and interpreting written material, quantitative and qualitative data
  • Writing clear and concise reports and memos
  • High level of personal and spatial organization
  • Strong interpersonal and communication skills
  • Learning and betterment mindset
Responsibilities
  • Advancing existing and establishing new methods using mass spectrometry, HPLC, and electrophoretic methods to characterize RNA molecules
  • Representing the Analytical Development team in cross-functional meetings, presenting results, and providing scientific input
  • Participating in in-depth investigations, including orthogonal method evaluation, understanding RNA and oligonucleotide stability, and characterizing impurities
  • Exploring new technology and software to strengthen and streamline RNA and oligonucleotide characterization workflows
  • Maintaining external awareness of advances in the field through keeping updated on relevant publications, attending conferences and workshops
  • Collaborating within the Analytical team and with other functional teams
  • Using scientific and technical expertise for instrument maintenance and troubleshooting
  • Training and mentoring junior scientists
  • Performing assays, analyzing, interpreting, and reporting results in appropriate format
  • Performing additional duties and responsibilities as required

Tessera Therapeutics is pioneering Gene Writing™, a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. They are focused on expanding possibilities in genetic medicine through tissue-targeted non-viral delivery technology, addressing major unmet medical needs with potentially curative and accessible therapies.

Company Stage

Series C

Total Funding

$581.7M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

39%